top of page

Preclinical CRO

Screenshot 2024-09-06 at 3.24.29 PM.png

ADVANCED MULTI ORGAN HAEMODYNAMIC
MONITORING

Pioneering the ability to generate and evaluate high-quality, reproducible safety data in multiple vital organs in our preclinical non-GLP and GLP-certified facilities.

Co-designed projects with multidisciplinary clinical leads

Non-GLP and NATA- certified GLP facilities

Vertical integration with Florey's CRO, NTA to seamlessly translate into clinical application

4 surgical suites with 4 preclinical critical care units

New Therapies

Medical Devices

Diagnostic Tools

Advisory Service

What We Offer

In our non-GLP and NATA-certified GLP facilities, we are able to offer globally unique techniques for real-time assessment of multiple vital organs for preclinical safety evaluation of medical devices and drugs.

Vertically integrated for clinical translation

Seamlessly translate into clinical trials via Neurosciences Trials Australia (NTA), a global leader in clinical trials specialising in the central nervous system.

NTA-Stacked-Full White.png

Key Therapeutic Areas

Brain

Cardiovascular

Kidney

Executive Team

Director and Test Facility Manager

Professor Yugeesh Lankadeva

Quality Officer

Ms Sally Hood

Commercial Contracts Manager and Data Integrity Officer

Mr Athula Gamage

Head of Commercialisation

Mr Haydn Wright

Collaboration with Clinical Leads

Perioperative Clinical Lead

Associate Professor Lachlan Miles

Intensive Care Lead

Associate Professor Mark Plummer

Nephrology lead

Dr Emily See

Cardiothoracic Lead

Associate Professor Andrew Cochrane

bottom of page